Non-interventional study of the effectiveness and safety of Jardiance in patients with heart failure (HF) of reduced ejection fraction (HFrEF) compared to guideline-recommended non- SGLT2i therapy regimens in China: A sub-study of the postmarketing study of Jardiance among patients with heart failure in China